Can an oral peptide supplement deliver measurable results for pain and inflammation? In the first-ever human study on oral BPC-157, over 90% of participants experienced a reduction in pain—and more than 70% saw statistically significant and clinically meaningful relief on the validated PROMIS – Pain Intensity metric. Backed by research and trusted by leaders in functional medicine, Infiniwell’s BPC-157 Delayed Pro 500mcg is emerging as a powerful tool for supporting musculoskeletal healing, neuroprotection, and whole-body recovery.
Recovery archive
Published recovery field note
Oral BPC-157
Can an oral peptide supplement deliver measurable results for pain and inflammation? In the first-ever human study on oral BPC-157, over 90% of participants experienced a reduction in pain—and more than 70% saw statistically significant and clinically meaningful relief on the validated PROMIS – Pain Intensity metric. Backed by research and trusted by leaders in functional medicine, Infiniwell’s BPC-157 Delayed Pro 500mcg is emerging as a powerful tool for supporting musculoskeletal healing, neuroprotection, and whole-body recovery.
Context first
Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.
Connected topics